Chapman, SR and Fitzpatrick, RW and Aladul, MI (2016) Did Cost Inhibit the Uptake of More potent Statins? Pharmacoepidemiology and Drug Safety, 25 (S1). pp. 3-23. ISSN 1099-1557

This is the latest version of this item.

[img]
Preview
Text
Did cost inhibit the uptake of more potent statins %281%29 (1).pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial.

Download (17kB) | Preview
Item Type: Article
Additional Information: Abstract of paper presented at Prescribing and Research in Medicines Management (UK & Ireland) Conference 2016 Health Foundation London January 29th 2016 “Ethics, Economics and the Future of Medicines – A Population Perspective” This is the peer reviewed version of the following abstract: Anon, 2016. Prescribing and Research in Medicines Management (UK & Ireland) Conference 2016 Health Foundation London January 29th 2016 “Ethics, Economics and the Future of Medicines - A Population Perspective.” Pharmacoepidemiol Drug Saf, 25, pp.3–23, which has been published in final form at http://dx.doi.org/10.1002/pds.4019 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.
Uncontrolled Keywords: statins, simvastatin, atorvastatin, generics, prescribing
Subjects: R Medicine > R Medicine (General)
R Medicine > RS Pharmacy and materia medica
Divisions: Faculty of Medicine and Health Sciences > Institute for Science and Technology in Medicine
Depositing User: Symplectic
Date Deposited: 29 Jun 2016 12:54
Last Modified: 18 Jul 2017 09:42
URI: http://eprints.keele.ac.uk/id/eprint/1922

Available Versions of this Item

Actions (login required)

View Item View Item